In 2023, the death rate due to alcohol-related liver cirrhosis among those aged 45-54 years was **** per 100,000. This statistic shows the rate of alcohol-related liver cirrhosis deaths in the U.S. in 2023, by age.

This statistic shows the death rate from liver cirrhosis in the U.S. in 2019, by age. According to the data, during that time the highest death rate was 37.9 per 100,000 and was among those aged 75-84 years.

In 2019, the global death rate from liver cirrhosis and other chronic liver diseases was over twice as high in men compared to women. Men reported over 24 deaths per 100,000 population, while women reported 11.7 deaths per 100,000 population. This statistic displays the age-standardized death rate (ASR) of liver cirrhosis and other chronic liver diseases worldwide in 2019, by gender.

In 2023, the state with the highest number of deaths due to chronic liver disease/cirrhosis was California, with 6,474 such deaths. This statistic shows the number of deaths from chronic liver disease/cirrhosis in the United States in 2023, by state.

Legacy unique identifier: P00207

This statistic shows the number of alcohol-related liver cirrhosis deaths in the U.S. from 2000 to 2019, by type of cirrhosis. According to the data, from 2017 to 2019 there were over 69 thousand alcohol-related cirrhosis deaths.

BackgroundLiver cirrhosis mortality number has increased over the last decades. We aimed to estimate the liver cirrhosis mortality rate and its trends for the first time by sex, age, geographical distribution, and cause in Iran.MethodIranian Death Registration System, along with demographic (Complete and Summary Birth History, Maternal Age Cohort and Period methods) and statistical methods (Spatio-temporal and Gaussian process regression models) were used to address the incompleteness and misclassification and uncertainty of death registration system to estimate annual cirrhosis mortality rate. Percentages of deaths were proportionally redistributed into cirrhosis due to hepatitis B, C and alcohol use based on the data from the Global Burden of Disease (GBD) 2010 study.ResultsLiver cirrhosis mortality in elder patients was 12 times higher than that in younger patients at national level in 2015. Over the 26 years, liver cirrhosis mortality in males has increased more than that in females. Plus, the percentage of change in age adjusted mortality rate at provincial levels varied between decreases of 64.53% to nearly 17% increase. Mortality rate has increased until 2002 and then decreased until 2015.The province with highest mortality rate in 2015 has nearly two times greater rate compare to the lowest. More than 60% of liver cirrhosis mortality cases at national level are caused by hepatitis B and C infection. The rate of hepatitis B mortality is four times more than that from hepatitis C.ConclusionThis study demonstrated an increasing and then decreasing pattern in cirrhosis mortality that could be due to national vaccination of hepatitis B program. However monitoring, early detection and treatment of risk factors of cirrhosis, mainly in high risk age groups and regions are essential. Cirrhosis mortality could be diminished by using new non-invasive methods of cirrhosis screening, hepatitis B vaccination, definite treatment of hepatitis C.

In 2023, the state with the highest rate of death due to chronic liver disease/cirrhosis was New Mexico, with around 32 deaths per 100,000 population. In comparison, Hawaii had a death rate of just 7.5 per 100,000 population at that time. This statistic shows the rates of death from chronic liver disease/cirrhosis in the United States in 2023, by state.

National and provincial age standardized mortality rate in Iran (per 100,000) for both sexes and the percentage of change (Δ).

BackgroundLiver cirrhosis-related death is a serious threat worldwide. The number of studies exploring the mortality trend of cirrhosis caused by specific etiologies was limited. This study aimed to demonstrate the pattern and trend based on the data of global burden of disease (GBD).MethodsThe data of cirrhosis mortality were collected from the GBD 2017. The Age standardized mortality rate (ASR) and estimated annual percentage changes (EAPC) were used to estimate the temporal trend of liver cirrhosis mortality by etiologies, regions, sociodemographic index (SDI), and sexes.ResultsGlobally, mortality cases of cirrhosis increased by 47.15%. Although the global ASR of cirrhosis mortality remained stable during this period, the temporal trend varied in etiologies. The ASR of mortality caused by hepatitis C virus (HCV), alcohol consumption, and non-alcoholic steatohepatitis (NASH) increased with an EAPC of 0.17 (95% CI, 0.14–0.20), 0.20 (95% CI, 0.16–0.24), 1.00 (95% CI, 0.97–1.04), respectively. A decreasing trend of ASR was found among the causes of hepatitis B virus (BV) and other causes. The increased pattern was heterogeneous worldwide. The most pronounced increase trend was found in middle-high SDI regions and Eastern Europe. Contrarily, the most pronounced decrease trend was found in low SDI regions and Western Sub-Saharan Africa.ConclusionCirrhosis is still a public health problem. The growth trend of cirrhosis mortality caused by HCV was slowed by promoting direct-acting antiviral therapy. Unfortunately, we observed an unfavorable trend in etiologies for alcohol consumption and NASH, which indicated that more targeted and specific strategies should be established to limit alcohol consumption and promote healthy lifestyles in high-risk countries, especially in middle-high SDI regions and Eastern Europe.

This update of the liver disease profiles data tool includes:

• hospital admission rate due to liver disease
• hospital admission rate for alcoholic liver disease
• hospital admission rate for non-alcoholic fatty liver disease (NAFLD)

Data has been refreshed to the 2020 geographies.

Liver disease is one of the main causes of premature mortality nationally. The profiles are designed to support local authorities by providing data in a user-friendly format to allow them to assess the effect of liver disease in their areas and take action to prevent it.

Data are presented by upper tier local authority, former Government Office Region and England. Lower tier local authority level data are also presented, where available.

Liver cirrhosis is a significant yet largely preventable and underappreciated cause of global health loss. This study aimed to profile the global and regional burdens of liver cirrhosis between 2010 and 2019 and the contributions of various aetiologies. Data on the incidence, mortality, and disability-adjusted life years (DALYs) of cirrhosis were obtained from the Global Burden of Disease 2019 study. The burden of cirrhosis was estimated by age, sex, region, aetiology, and socio-demographic index (SDI). The temporal trend was quantified using the annual percentage changes (APC.) Globally, there were 2.05 million new cases and 1.47 million deaths due to cirrhosis in 2019. From 2010 to 2019, the age-standardized incidence rate (ASIR) for cirrhosis increased slightly from 25.19 to 25.35 worldwide, while the age-standardized death rate (ASDR) and age-standardized DALYs (ASDALYs) decreased from 20.37 to 18.00 and 639.86 to 560.43, respectively. Cirrhosis incidence, mortality and DALYs were consistently higher in males than females. Stratification according to the socio-demographic index (SDI) revealed that low SDI countries had the highest ASDR and ASDALYs in 2019, while middle SDI countries had the highest ASIR. Regarding the aetiology of cirrhosis, hepatitis C accounted for the largest proportion of cirrhosis-related incidence (26.9%), death (26.8%) and DALYs (26.3%); however, non-alcoholic fatty liver disease (NAFLD) exhibited a rapidly growing cause of incident cirrhosis (+26.7%), cirrhosis-related death (+25.1%), and DALYs (+21.0%) worldwide during this period. The ASIR for NAFLD also significantly increased with APC 1.080 over the study period. Albeit the global burden of cirrhosis incidence increased from 2010 to 2019, cirrhosis-associated deaths and DALYs declined significantly. Notably, NAFLD exhibited the most significant increase as a contributor to cirrhosis worldwide. Global burden of cirrhosis incidence increased from 2010 to 2019.Cirrhosis-associated death and DALYs declined significantly during this period.Non-alcoholic fatty liver disease (NAFLD) exhibited the most significant increase as a contributor to cirrhosis worldwide. Global burden of cirrhosis incidence increased from 2010 to 2019. Cirrhosis-associated death and DALYs declined significantly during this period. Non-alcoholic fatty liver disease (NAFLD) exhibited the most significant increase as a contributor to cirrhosis worldwide.

Death rate due to chronic liver disease, by sex (number of deaths per 100 000 inhabitants, adjusted to a standard age distribution, and as defined by the International Statistical Classification of Diseases and Related Health Problems (ICD)).

Poland Deaths: Urban: Male: DS: ow Alcoholic Liver Disease data was reported at 2,746.000 Person in 2023. This records a decrease from the previous number of 2,971.000 Person for 2022. Poland Deaths: Urban: Male: DS: ow Alcoholic Liver Disease data is updated yearly, averaging 2,065.500 Person from Dec 2006 (Median) to 2023, with 18 observations. The data reached an all-time high of 3,031.000 Person in 2021 and a record low of 1,140.000 Person in 2006. Poland Deaths: Urban: Male: DS: ow Alcoholic Liver Disease data remains active status in CEIC and is reported by Statistics Poland. The data is categorized under Global Database’s Poland – Table PL.G006: Deaths: By Cause.

This statistic shows the death rates from liver cirrhosis in the U.S. from 1910 to 2019, by gender. According to the data, in 2019, males had a cirrhosis death rate of **** per 100,000 population compared to a rate of *** among females.

This statistic depicts the percentage of alcohol-related deaths globally as a percentage of deaths from select diseases in 2016. According to the data, among deaths due to liver cirrhosis, ** percent were related to alcohol use.

Annual data on deaths caused by unspecified hepatitis, and fibrosis and cirrhosis of the liver in the UK. Age-standardised rates for alcohol-specific deaths by deprivation quintile in England.

Objective The incidence of chronic liver disease due to non-alcoholic fatty liver disease (NAFLD) is gradually increasing worldwide. This study assessed the disease burden of liver cirrhosis related to NAFLD in China from 1990 to 2021 and predicted future trends.Methods Data were obtained from the Global Burden of Disease (GBD) 2021 study. Joinpoint model was used to calculate the trend changes of liver cirrhosis related to NAFLD in China, and age-period-cohort analyse was used to estimate the independent effects of age, period, and cohort. ARIMA model was used to predict the prevalence in the next 15 years.Results In 2021, the incidence of cirrhosis related to NAFLD in China was 672.02/100,000, the prevalence was 20,470.78/100,000, and the mortality rate was 0.45/100,000.The 1990-2021 age-standardized incidence rate (ASIR) mean annual percentage change (AAPC) was 0.74 % (95% CI = 0.69 %- 0.78%). There was a decreasing trend in the age standardized death rate (ASDR) with an AAPC of -1.73% (95%CI = −2.06% - −1.40%). The age effect showed an overall fluctuating downward trend in incidence with age. Mortality showed an overall increasing trend. The period effect showed an overall decreasing and then increasing trend in period rate ratios (RR), with the highest risk of morbidity in 2017-2021, the period RR of morbidity = 1.16 (95% CI = 1.11,1.21); and a decreasing trend in mortality, with the highest risk of death in 1992-1996, the risk RR of mortality = 1.50 (95% CI = 1.43,1.58). The cohort effect showed a significant increase in the risk of incidence and a decreasing trend in the risk of mortality from 1977-2002. The ASIR is projected to increase from 621.18/100,000 to 662.27/100,000 over the next 15 years. Of these, ASIR is predicted to decrease in males and increase substantially in females. ASDR for the whole population will decrease from 0.31/100,000 to 0.29/100,000 people. Of these, the ASDR is projected to decrease slightly for males and increase slightly for females.Conclusions The future incidence of liver cirrhosis related to NAFLD in China from 1990 to 2021 still shows an increasing trend. More attention needs to be paid to young men and postmenopausal women, and targeted public health interventions focusing on NAFLD management are urgently needed.

Background: Alcohol is the main cause of liver cirrhosis. The objective of this study was to analyze the mortality rates of alcohol-related cirrhosis in Mexico from 2000 to 2017.Methods: Mortality data from alcohol-related cirrhosis were obtained from the National Institute of Statistics and Geography. Rates were adjusted to the World Standard Population and were calculated with a direct method. The differences between genders were evaluated with Student's t-test, while the ANOVA test was used for differences among age groups. A trend analysis was performed with an ln regression of adjusted mortality rates and analyzed with Student's t-test.Results: The mean age-adjusted mortality rate during the study period was 13.28 per 100,000 inhabitants. A significant decrease in mortality rates was observed, from 20.55 to 10.62 per 100,000 inhabitants. All age groups studied showed a significant decrease in mortality. The mortality rate was higher in males than in females.Conclusions: Mortality from alcohol-related cirrhosis decreased in Mexico. Males still have the highest mortality rate.